CYBB
MOLECULAR TARGETcytochrome b-245 beta chain
CYBB (cytochrome b-245 beta chain) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYBB
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ebselen | 4.74 | 113 |
| 2 | diphenyleneiodonium chloride | 2.48 | 11 |
| 3 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.95 | 6 |
| 4 | Apigenin 5,7,4'-trihydroxy-flavone, | 1.61 | 4 |
| 5 | chrysin | 1.61 | 4 |
| 6 | celastrol | 0.69 | 1 |
| 7 | Naloxone | 0.69 | 1 |
About CYBB as a Drug Target
CYBB (cytochrome b-245 beta chain) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented CYBB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYBB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.